Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMC125 Roll-over for DUET Trial Participants
NCT00359021Phase 3Completed
- Sponsor
- Tibotec
- Start
- Jun 2006
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 14
01
Overview
Phase 3, open-label, single-arm trial of etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Primary endpoint: Number of Participants Experiencing Adverse Events. Started Jun 2006; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00359021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00359021.